XNCR Q3 2022 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+38.7% YoY

Gross Profit

-$26M-95.1% margin

Operating Income

-$38M-140.5% margin

Net Income

-$33M-120.0% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

-9.5%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$16M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$835M

Total Liabilities

$113M

Stockholders' Equity

$723M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$20M	+38.7%
Gross Profit	-$26M	-$31M	+16.0%
Operating Income	-$38M	-$41M	+7.1%
Net Income	-$33M	-$40M	+18.5%

Revenue Segments

Royalties

$27M100%

Research collaboration

$100,0000%